546 related articles for article (PubMed ID: 18462850)
1. Potentiation of an anthrax DNA vaccine with electroporation.
Luxembourg A; Hannaman D; Nolan E; Ellefsen B; Nakamura G; Chau L; Tellez O; Little S; Bernard R
Vaccine; 2008 Sep; 26(40):5216-22. PubMed ID: 18462850
[TBL] [Abstract][Full Text] [Related]
2. Comparative performance of a licensed anthrax vaccine versus electroporation based delivery of a PA encoding DNA vaccine in rhesus macaques.
Livingston BD; Little SF; Luxembourg A; Ellefsen B; Hannaman D
Vaccine; 2010 Jan; 28(4):1056-61. PubMed ID: 19896452
[TBL] [Abstract][Full Text] [Related]
3. A plant based protective antigen [PA(dIV)] vaccine expressed in chloroplasts demonstrates protective immunity in mice against anthrax.
Gorantala J; Grover S; Goel D; Rahi A; Jayadev Magani SK; Chandra S; Bhatnagar R
Vaccine; 2011 Jun; 29(27):4521-33. PubMed ID: 21504775
[TBL] [Abstract][Full Text] [Related]
4. An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits.
Wimer-Mackin S; Hinchcliffe M; Petrie CR; Warwood SJ; Tino WT; Williams MS; Stenz JP; Cheff A; Richardson C
Vaccine; 2006 May; 24(18):3953-63. PubMed ID: 16530302
[TBL] [Abstract][Full Text] [Related]
5. Nasal immunization with a dual antigen anthrax vaccine induced strong mucosal and systemic immune responses against toxins and bacilli.
Sloat BR; Cui Z
Vaccine; 2006 Sep; 24(40-41):6405-13. PubMed ID: 16828937
[TBL] [Abstract][Full Text] [Related]
6. Electroporation of a multivalent DNA vaccine cocktail elicits a protective immune response against anthrax and plague.
Albrecht MT; Livingston BD; Pesce JT; Bell MG; Hannaman D; Keane-Myers AM
Vaccine; 2012 Jul; 30(32):4872-83. PubMed ID: 22633906
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of anthrax vaccines using protective antigen-expressing viral replicon vectors.
Wang HC; An HJ; Yu YZ; Xu Q
Immunol Lett; 2015 Feb; 163(2):206-13. PubMed ID: 25102364
[TBL] [Abstract][Full Text] [Related]
8. [Immunogenicity of the recombinant Bacillus strains with cloned gene of biosynthesis of protective antigen against Bacillus anthracis].
Mikshis NI; Kudriavtseva OM; Bolothikova MF; Shulepov DV; Novikova LV; Popov IuA; Shchukovskaia TN; Drozdov IG; Kutyrev VV
Mol Gen Mikrobiol Virusol; 2007; (3):15-21. PubMed ID: 17886469
[TBL] [Abstract][Full Text] [Related]
9. A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores.
Hermanson G; Whitlow V; Parker S; Tonsky K; Rusalov D; Ferrari M; Lalor P; Komai M; Mere R; Bell M; Brenneman K; Mateczun A; Evans T; Kaslow D; Galloway D; Hobart P
Proc Natl Acad Sci U S A; 2004 Sep; 101(37):13601-6. PubMed ID: 15342913
[TBL] [Abstract][Full Text] [Related]
10. Nasal immunization with the mixture of PA63, LF, and a PGA conjugate induced strong antibody responses against all three antigens.
Sloat BR; Shaker DS; Le UM; Cui Z
FEMS Immunol Med Microbiol; 2008 Mar; 52(2):169-79. PubMed ID: 18194342
[TBL] [Abstract][Full Text] [Related]
11. Poly-gamma-d-glutamic acid and protective antigen conjugate vaccines induce functional antibodies against the protective antigen and capsule of Bacillus anthracis in guinea-pigs and rabbits.
Lee DY; Chun JH; Ha HJ; Park J; Kim BS; Oh HB; Rhie GE
FEMS Immunol Med Microbiol; 2009 Nov; 57(2):165-72. PubMed ID: 19732139
[TBL] [Abstract][Full Text] [Related]
12. Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein.
Price BM; Liner AL; Park S; Leppla SH; Mateczun A; Galloway DR
Infect Immun; 2001 Jul; 69(7):4509-15. PubMed ID: 11401993
[TBL] [Abstract][Full Text] [Related]
13. Topical immunization onto mouse skin using a microemulsion incorporated with an anthrax protective antigen protein-encoding plasmid.
Cui Z; Sloat BR
Int J Pharm; 2006 Jul; 317(2):187-91. PubMed ID: 16730934
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the immune response induced by a nasal anthrax vaccine based on the protective antigen protein in anaesthetized and non-anaesthetized mice.
Sloat BR; Cui Z
J Pharm Pharmacol; 2006 Apr; 58(4):439-47. PubMed ID: 16597361
[TBL] [Abstract][Full Text] [Related]
15. Genetic immunization against anthrax.
Galloway D; Liner A; Legutki J; Mateczun A; Barnewall R; Estep J
Vaccine; 2004 Apr; 22(13-14):1604-8. PubMed ID: 15068841
[TBL] [Abstract][Full Text] [Related]
16. Anthrax protective antigen administered by DNA vaccination to distinct subcellular locations potentiates humoral and cellular immune responses.
Midha S; Bhatnagar R
Eur J Immunol; 2009 Jan; 39(1):159-77. PubMed ID: 19130551
[TBL] [Abstract][Full Text] [Related]
17. Progress and novel strategies in vaccine development and treatment of anthrax.
Chitlaru T; Altboum Z; Reuveny S; Shafferman A
Immunol Rev; 2011 Jan; 239(1):221-36. PubMed ID: 21198675
[TBL] [Abstract][Full Text] [Related]
18. Plasmid-based vaccination with candidate anthrax vaccine antigens induces durable type 1 and type 2 T-helper immune responses.
Zhang Y; Qiu J; Zhou Y; Farhangfar F; Hester J; Lin AY; Decker WK
Vaccine; 2008 Jan; 26(5):614-22. PubMed ID: 18166249
[TBL] [Abstract][Full Text] [Related]
19. The US capitol bioterrorism anthrax exposures: clinical epidemiological and immunological characteristics.
Doolan DL; Freilich DA; Brice GT; Burgess TH; Berzins MP; Bull RL; Graber NL; Dabbs JL; Shatney LL; Blazes DL; Bebris LM; Malone MF; Eisold JF; Mateczun AJ; Martin GJ
J Infect Dis; 2007 Jan; 195(2):174-84. PubMed ID: 17191162
[TBL] [Abstract][Full Text] [Related]
20. Protection of mice against challenge with Bacillus anthracis STI spores after DNA vaccination.
Hahn UK; Alex M; Czerny CP; Böhm R; Beyer W
Int J Med Microbiol; 2004 Jul; 294(1):35-44. PubMed ID: 15293452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
